BioSpace News Archive

Achilles Therapeutics to Present at Upcoming Investor Conferences in September 2021

Achilles Therapeutics plc, a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, announced that management will present at the following investor conferences in September.

September 2, 2021
·
1 min read
Pharm Country

Harmony Biosciences Announces Inclusion Of WAKIX® (pitolisant) In American Academy Of Sleep Medicine’s Updated Clinical Practice Guideline

Harmony Biosciences Holdings, Inc. (“Harmony”) (Nasdaq: HRMY), today announced that the American Academy of Sleep Medicine (AASM) has published an updated clinical practice guideline which includes WAKIX® (pitolisant) as a recommended treatment option for adults living with narcolepsy.

September 2, 2021
·
8 min read
Biotech Beach

Neurana Pharmaceuticals to Present at Wells Fargo Virtual Healthcare Conference - Sep 02, 2021

Neurana Pharmaceuticals, a biotechnology company focused on the treatment of neuromuscular conditions, announced that Craig Thompson, President and Chief Executive Officer, will present at the Wells Fargo Virtual Healthcare Conference and participate in one-on-one meetings with investors.

September 2, 2021
·
1 min read
Biotech Bay

Quantum Leap Healthcare Collaborative Concludes Famotidine Celebrex combination Does Not Reduce Time to Recovery or Mortality in Critically Ill Patients in the I-SPY COVID Trial

Quantum Leap Healthcare Collaborative (QLHC), the sponsor of the I-SPY COVID Trial, today announced that the Famotidine Celecoxib arm has been dropped from the trial due to futility, based on the low likelihood of success.

September 2, 2021
·
5 min read
Pharm Country

Xylyx Bio Awarded $2.2M NIH SBIR Fast-Track Grant from National Heart, Lung, and Blood Institute

Xylyx Bio, Inc., a biotechnology company developing groundbreaking solutions for drug discovery and tissue modeling and repair, announced today that it has been awarded a Small Business Innovation Research (SBIR) Fast-Track grant from the National Heart, Lung, and Blood Institute

September 2, 2021
·
2 min read
Genetown

Infinity to Participate in Wells Fargo and H.C. Wainwright Investor Conferences

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI), today announced that the Company will participate in Wells Fargo’s Virtual Healthcare Conference and H.C. Wainwright’s 23rd Annual Global Investment Conference.

September 2, 2021
·
2 min read
Business

Emmaus Life Sciences Reports Financial Results for the Six Months Ended June 30, 2021

Emmaus Life Sciences, Inc. (OTC: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today announced financial results for the six months ended June 30, 2021.

September 2, 2021
·
5 min read
Pharm Country

Delcath Systems to Present at Upcoming Virtual Investor Conferences in September 2021

Delcath Systems, Inc., an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced it will participate in three upcoming conferences.

September 2, 2021
·
2 min read
Pharm Country

BioRestorative Therapies Receives Patent in Australia Related to its Off-the-Shelf ThermoStem® Program

BioRestorative Therapies, Inc. (the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that the Australian Patent Office has issued the Company a patent related to its metabolic ThermoStem® Program.

September 2, 2021
·
3 min read
Biotech Beach

ResMed Announces Participation in the Morgan Stanley 19th Annual Global Healthcare Conference

ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a virtual fireside chat at the Morgan Stanley 19th Annual Global Healthcare Conference on Thursday, September 9, 2021, beginning at approximately 1:15 p.m. (Eastern Daylight Time) via video webcast.

September 2, 2021
·
1 min read